Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Blennow

Showing results (1-10 of 289) with videos related to

Pageof 29
Sort By:
Journal of Internal Medicine|August 25, 2004
CSF biomarkers for mild cognitive impairmentK Blennow
International Psychogeriatrics|June 18, 1998
Neurochemical dissection of synaptic pathology in Alzheimer's diseaseP Davidsson, K Blennow
Journal of Internal Medicine|July 28, 2018
Biomarkers for Alzheimer's disease: current status and prospects for the futureK Blennow, H Zetterberg
Acta Neurochirurgica|January 1, 1995
Detection of cerebrospinal fluid leakage by isoelectric focusing on polyacrylamide gels with silver staining using the PhastSystemK Blennow, P Fredman
The Journal of Nutrition, Health & Aging|March 21, 2009
Use of CSF biomarkers in Alzheimer's disease clinical trialsK Blennow, H Zetterberg
Alzheimer Disease and Associated Disorders|January 1, 1991
Pathogenetic basis of vascular dementiaA Wallin, K Blennow
Lakartidningen|March 31, 1993
[The concept of dementia--does it enlighten or confuse?]A Wallin, K Blennow
Journal of Geriatric Psychiatry and Neurology|April 1, 1992
Clinical heterogeneity of probable Alzheimer's diseaseK Blennow, A Wallin
Acta Neurologica Scandinavica. Supplementum|January 1, 1992
Clinical diagnosis of Alzheimer's disease by primary care physicians and specialistsA Wallin, K Blennow
The Journal of Prevention of Alzheimer'S Disease|December 14, 2017
Amyloid and Tau Biomarkers in CSFK Blennow, H Zetterberg
Pageof 29

Showing results (1-10 of 289) with videos related to

Sort By:
Pageof 29
Journal of Internal Medicine|August 25, 2004
CSF biomarkers for mild cognitive impairmentK Blennow
International Psychogeriatrics|June 18, 1998
Neurochemical dissection of synaptic pathology in Alzheimer's diseaseP Davidsson, K Blennow
Journal of Internal Medicine|July 28, 2018
Biomarkers for Alzheimer's disease: current status and prospects for the futureK Blennow, H Zetterberg
Acta Neurochirurgica|January 1, 1995
Detection of cerebrospinal fluid leakage by isoelectric focusing on polyacrylamide gels with silver staining using the PhastSystemK Blennow, P Fredman
The Journal of Nutrition, Health & Aging|March 21, 2009
Use of CSF biomarkers in Alzheimer's disease clinical trialsK Blennow, H Zetterberg
Alzheimer Disease and Associated Disorders|January 1, 1991
Pathogenetic basis of vascular dementiaA Wallin, K Blennow
Lakartidningen|March 31, 1993
[The concept of dementia--does it enlighten or confuse?]A Wallin, K Blennow
Journal of Geriatric Psychiatry and Neurology|April 1, 1992
Clinical heterogeneity of probable Alzheimer's diseaseK Blennow, A Wallin
Acta Neurologica Scandinavica. Supplementum|January 1, 1992
Clinical diagnosis of Alzheimer's disease by primary care physicians and specialistsA Wallin, K Blennow
The Journal of Prevention of Alzheimer'S Disease|December 14, 2017
Amyloid and Tau Biomarkers in CSFK Blennow, H Zetterberg
Pageof 29